NextCell Pharma presents at the Advanced Therapies Europe conference

NextCell Pharma participates in Advanced Therapies Europe, a European conference in Portugal on advanced cell therapies. NextCell's CSO Dr. Lindsay Davies will talk about NextCell's platform technology and the internationally recognized research generated during the development of drug product ProTrans for type 1 diabetes.

NextCell Pharma was invited to present at the Advanced Therapies Europe conference, which will take place 5 – 7 September 2023 in Portugal. NextCell participates through CEO Mathias Svahn and CSO Lindsay Davies who will talk about NextCell's research with the cell therapy drug ProTrans for the treatment of type 1 diabetes.

– For NextCell, the conference is a very good arena to present data from our clinical trials and establish contacts with potential partners and licensees for our drug candidate ProTrans, says NextCells Pharma's CEO Mathias Svahn.

Link to Advanced Therapies Europe  https://advancedtherapieseurope.phacilitate.com